Results 141 to 150 of about 23,896 (206)

Clinical Remission Outcome in Chinese Patients With Severe Asthma With an Eosinophilic Phenotype Receiving Mepolizumab: A Post-hoc Analysis of a Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial [PDF]

open access: diamond
Ruchong Chen   +14 more
openalex   +1 more source

Long-Term Clinical Remission on Benralizumab Treatment in Severe Eosinophilic Asthma: A Four-Year Real-Life Study. [PDF]

open access: yesJ Clin Med
Quarato CMI   +8 more
europepmc   +1 more source

Efficacy and safety of benralizumab in elderly patients with severe eosinophilic asthma. [PDF]

open access: yesEur Clin Respir J
Somekawa K   +19 more
europepmc   +1 more source

Clinical characterisation of exacerbations of severe eosinophilic asthma occurring on mepolizumab and placebo. [PDF]

open access: yesERJ Open Res
Howell I   +6 more
europepmc   +1 more source

Long-Term Eosinophil Depletion: A Real-World Perspective on the Safety and Durability of Benralizumab Treatment in Severe Eosinophilic Asthma. [PDF]

open access: yesJ Clin Med
Menzella F   +21 more
europepmc   +1 more source

Severe Eosinophilic Asthma and Severe Mixed Polyneuropathy: A Case of Eosinophilic Granulomatous Vasculitis With Polyangiitis and New Therapeutic Perspectives

open access: gold
María del Carmen Lorenzo Martínez   +6 more
openalex   +1 more source

Case Report: Dual monoclonal antibody therapy in chronic rhinosinusitis with nasal polyps and severe eosinophilic asthma-a proteome analysis. [PDF]

open access: yesFront Allergy
Blauwblomme M   +12 more
europepmc   +1 more source

Effects of benralizumab in patients with severe eosinophilic asthma (SEA): A plain language summary of the ANANKE study. [PDF]

open access: yesImmunotherapy
Canonica GW   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy